Relapsing polychondritis revealed by < sup > 18 < /sup > F-FDG and Al < sup > 18 < /sup > F-NOTA-FAPI-04 PET/CT
Hell J Nucl Med. 2022 Jan-Apr;25(1):108-110. doi: 10.1967/s002449912441. Epub 2022 Apr 8.NO ABSTRACTPMID:35388809 | DOI:10.1967/s002449912441 (Source: Hellenic Journal of Nuclear Medicine)
Source: Hellenic Journal of Nuclear Medicine - April 7, 2022 Category: Nuclear Medicine Authors: Ming Ni Qiang Xie Xingxing Zhu Weifu Lv Source Type: research

Relapsing polychondritis revealed by < sup > 18 < /sup > F-FDG and Al < sup > 18 < /sup > F-NOTA-FAPI-04 PET/CT
Hell J Nucl Med. 2022 Apr 8:s002449912441. doi: 10.1967/s002449912441. Online ahead of print.NO ABSTRACTPMID:35388809 | DOI:10.1967/s002449912441 (Source: Hellenic Journal of Nuclear Medicine)
Source: Hellenic Journal of Nuclear Medicine - April 7, 2022 Category: Nuclear Medicine Authors: Ming Ni Qiang Xie Xingxing Zhu Weifu Lv Source Type: research

Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):1789. doi: 10.26355/eurrev_202203_28320.NO ABSTRACTPMID:35363323 | DOI:10.26355/eurrev_202203_28320 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - April 1, 2022 Category: Drugs & Pharmacology Authors: M Tang Q-P Xie K Zhu X-L Fu Source Type: research

Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):1789. doi: 10.26355/eurrev_202203_28320.NO ABSTRACTPMID:35363323 | DOI:10.26355/eurrev_202203_28320 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 1, 2022 Category: Drugs & Pharmacology Authors: M Tang Q-P Xie K Zhu X-L Fu Source Type: research

Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):1789. doi: 10.26355/eurrev_202203_28320.NO ABSTRACTPMID:35363323 | DOI:10.26355/eurrev_202203_28320 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - April 1, 2022 Category: Drugs & Pharmacology Authors: M Tang Q-P Xie K Zhu X-L Fu Source Type: research